Authors


Leslie Solomon

Latest:

Culture-building is a Business Imperative Amid COVID-19

Crisis tests a business's culture. It also is a good time to create or strengthen a culture.


Steve Wendling

Latest:

How Health Insurers Can Adapt to the New Normal

In order to navigate the new landscape COVID-19 has brought along with it and connect with consumers who may be feeling confused and stressed out, lesser-known health insurers will need to introduce themselves to this new audience.


Bhrugu Pange

Latest:

Trusted Networks Key to Moving Forward

Sharing technologies like blockchain could help healthcare institutions establish a consistent, accurate, and trustworthy approach to data collection and dissemination.


Sheetal Chawla

Latest:

The Convergence of High Tech and Healthcare

The growth of digital twin technology — paired with the transition towards personalized medicine — has left many healthcare industry professionals evaluating the potential of a “patient twin.”


Ryne Natzke

Latest:

4 Reasons Why Unaffordable Medical Bills Are an Important Social Determinant of Health

Medical debt can send people into “a spiral of economic disadvantage,” including a lack of stability and security in personal life, housing and work.


Richard Fu

Latest:

Can Providers Become Payers? It Can Work If Health Systems Keep These Points in Mind

The ‘payvider’ model is best suited for health systems that want to double down on value-based care.


Andrew Cox, Pharm.D., MBA

Latest:

Caregiver Burden and Value Assessments in Duchenne Muscular Dystrophy

Doing more to incorporate caregiver burden into value assessments and cost-effectiveness research of Duchene muscular dystrophy treatments was the focus of a recent International Society for Pharmacoeconomics and Outcomes Research (ISPOR) webinar.


Cameron Santoro

Latest:

Teledermatology Improves Outcomes and Reduces Costs | AAD 2025

A reduction in emergency room visits is just one of the ways teledermatology has improved patient outcomes and reduced costs, according to Elizabeth K. Jones, M.D., an associate dermatology professor at Thomas Jefferson University Hospital in Philadelphia.


Ramin Davidoff, M.D.

Latest:

Healthcare’s Digital Transformation Improves Lives, Not Just Efficiencies

COVID-19 sped up healthcare’s digital transformation. The 20-minute telehealth visit can mean less unpaid time off from work and the difference between seeking care and putting food on the table. Care-at-home programs can reduce the risks associated with hospitalization, such as hospital-acquired infections.


Khalid Al-Maskari

Latest:

Why the Future of Health Care is Mobile

Five years ago, health care providers didn’t see mobile as a priority or a necessary tool in improving the patient experience. The pandemic changed that.


Maritn Rosenzweig, MD

Latest:

Optimizing the Management of TRD

Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.


Melanie Silverman

Latest:

Medicaid Plans Need to Prioritize Maternal, Infant Telehealth

As payer and provider organizations look to improve health outcomes around the far-reaching impacts of the pandemic, they must consider the unique needs of some of our most vulnerable populations, such as new and expecting mothers and their infants.


Jill Zouzoulas, MD, FACR, Tryon Medical Partners

Latest:

Future Predictions for Intravenous and Subcutaneous Biologics

An expert in the field of rheumatology predicts how the treatment landscape will evolve for intravenous and subcutaneous therapies.


Morris Panner

Latest:

Enterprise Imaging: A Necessity – Not a Luxury – for Hospitals & Health Systems

Enterprise imaging platforms would enable organizations to consistently and optimally capture, index, manage, store, distribute, view, exchange and analyze all clinical imaging and multimedia content, enhancing patients’ electronic health records.



Lauren Biscaldi

Latest:

Takeaways from Senate Hearing on Semaglutide Pricing

Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not impact formulary coverage.



Denise Myshko

Latest:

New Trial to Investigate Osteoporosis Drug for Type 1 Diabetes

The study explores whether Prolia/Xgeva (denosumab), a widely used therapy for osteoporosis and bone tumors, can regenerate beta cells in patients with early type 1 diabetes.


Tracy Baroni Allmon, J.D

Latest:

Pressure on Patient Assistance Programs | Predictions for 2025

Predictions for 2025 by Tracy Baroni Allmon, J.D., vice president of Market Access and Policy at Magnolia Market Access.


Eric K. Singhi, M.D.

Latest:

Evaluating Five-Year Efficacy Outcomes in EMPOWER-LUNG 1

Panelists discuss how the five-year prognosis for advanced non-small cell lung cancer (NSCLC) has improved with PD-1 inhibitors, showing promising overall survival (OS) and progression-free survival (PFS). Cemiplimab’s outcomes align well with other PD-1/PD-L1 inhibitors, influencing clinical decisions for its use as a first-line treatment.


Carolina Nascimento

Latest:

Digital Transformation is the Revolutionary Change Healthcare Needs

Due to one of the most challenging global crises in living memory and one that presented an acute challenge for the medical community, healthcare providers find themselves operating within an uncertain landscape. They are still managing the fallout of COVID-19 while also planning for the future.


Sobha Pisharody

Latest:

Precision Medicine vs Trial and Error: Why Pharmacogenomics is Increasingly Relevant

Pharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.


Thomas Foley

Latest:

Closing the Gap With Virtual Care Services: Reimagining the Delivery of Healthcare

The delivery of care model needs to scale across the community settings while servicing the unique needs of each patient.


Jaime Rosenberg

Latest:

Study: Medicaid Coverage Uneven for Gene Therapies

Recent study finds that Medicaid coverage for some of the first gene and cell therapies was at times delayed and not consistent with federal requirements.


Nate Allen

Latest:

Digital Patient Engagement: Helping Uninsured Americans Gain Access to Care

Identifying the right payer before a healthcare service is provided and billing on time, reduces costs, prevents bad debt and maximizes reimbursements and revenue.


Solveig Dittmann

Latest:

Acute Hospital-at-Home Holds Promise for Hospitals Facing Staffing Shortages

Organizations setting up hospital-at-home programs need to be aware of the associated risks and mitigation best practices.


Vinay Mummigatti, EVP of Strategy at Skan

Latest:

Reimagining healthcare payer operations: the power of process intelligence

How AI-powered technology and its data-driven insights improve payer operations and reimburse providers faster.


Janet Walker

Latest:

Getting Real About Health Equity

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.


Angie Meoli

Latest:

Collaborating to Support Better Outcomes Through Value-Based Care

Engaging with payers in collaborative arrangements is critical for achieving quality outcomes at lower cost, while ensuring financial health for providers during good times and bad.


Jonathan E. Levitt

Latest:

Why Timing Matters When It Comes to PBM Contracting

Plan sponsors should begin evaluation of PBM performance at least a year before the contract expires, say lawyers with expertise in PBM contracting.

© 2025 MJH Life Sciences

All rights reserved.